Processing

Please wait...

Settings

Settings

Goto Application

Offices all Languages Stemming false Single Family Member true Include NPL false
RSS feed can only be generated if you have a WIPO account

Save query

A private query is only visible to you when you are logged-in and can not be used in RSS feeds

Query Tree

Refine Options

Offices
All
Specify the language of your search keywords
Stemming reduces inflected words to their stem or root form.
For example the words fishing, fished,fish, and fisher are reduced to the root word,fish,
so a search for fisher returns all the different variations
Returns only one member of a family of patents
Include Non-Patent literature in results

Full Query

IC:A61K36/00

Side-by-side view shortcuts

General
Go to Search input
CTRL + SHIFT +
Go to Results (selected record)
CTRL + SHIFT +
Go to Detail (selected tab)
CTRL + SHIFT +
Go to Next page
CTRL +
Go to Previous page
CTRL +
Results (First, do 'Go to Results')
Go to Next record / image
/
Go to Previous record / image
/
Scroll Up
Page Up
Scroll Down
Page Down
Scroll to Top
CTRL + Home
Scroll to Bottom
CTRL + End
Detail (First, do 'Go to Detail')
Go to Next tab
Go to Previous tab

Analysis

1.202022106782Antiurolithiatische, antiosteoporotische, antidiabetische und entzündungshemmende Zusammensetzung eines Polykräuterextraktes
DE 26.01.2023
Int.Class A61K 36/59
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
59Menispermaceae (Moonseed family), e.g. hyperbaena or coralbead
Appl.No 202022106782 Applicant Azeemuddin Mohammed Inventor

Antiurolithiatische, antiosteoporotische, antidiabetische und entzündungshemmende Polykräuterextrakt-Zusammensetzung, umfassend: a) 100 mg Tinospora sinensis Stamm; b) 150 mg Moringa oleifera-Wurzelrinde; c) 250 mg Acacia sinuata-Schoten; d)Chondroitinsulfat(Standardarzneimittel); e) 0,75 % Ethylenglykol, wobei die Mischung aus wässrigem Extrakt aus Acacia sinuata-Schoten, methanolischem Extrakt aus Moringa oleifera-Wurzelrinde und ethanolischem Extrakt aus Tinospora sinensis-Stämmen im Verhältnis 1:2: 1 besteht und gegen Ethylenglykol-induzierte Urolithiasis, Diabetes, Entzündungen und Osteoporose wirkt, wobei 400mg/kg und 200mg/kg als hohe und niedrige Dosis gewählt wurden.

2.WO/2023/002507ECO-FRIENDLY BIOPROCESS FOR SEPARATION OF HEMP PLANT FIBRES FOR VARIOUS APPLICATIONS
WO 26.01.2023
Int.Class A61K 36/60
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
60Moraceae (Mulberry family), e.g. breadfruit or fig
Appl.No PCT/IN2022/050654 Applicant NAMRATA HEMPCO LIMITED Inventor SIRUPA, Harshaavardhan Redi
An eco-friendly bioprocess for separation of hemp plant fibres, from decorticated hemp fibres skin, said process comprising: pre-treating the decorticated hemp fibres skin with an aqueous solution, said aqueous solution bearing a pH in the range of 5.0 to 9.0, wherein said aqueous solution consisting of: 2.0 gm to 5.0 gm of a carbon source per 1 kg of hemp fibre; 1.0 gm to 5.0 gm of a nitrogen source per 1 kg of hemp fibre; biomaterial obtained from a bio-resource material; storing, for natural fermentation, at ambient temperature, in order to separate its fibres, for a time period ranging from 3.0 to 10 days; subsequently, washing the separated fibres with water having a pH in the range of 5.0 to 8.0; and treating the washed and separated fibres with one or more cleaning agent for more cleaner fibres.
3.WO/2023/003122COMPOSITION FOR INHIBITING CORONAVIRUS PROLIFERATION
WO 26.01.2023
Int.Class A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
Appl.No PCT/KR2022/003907 Applicant BEN'S LAB CO., LTD. Inventor JEONG, Jong Moon
The present invention relates to a composition for inhibiting coronavirus proliferation, comprising epigallocatechin gallate (EGCG) as an active ingredient, the composition being applicable locally to the oral cavity, nasal cavity, or the like, thus inhibiting the proliferation of coronavirus that causes respiratory diseases in epithelial cells of the oral cavity, nasal cavity, or the like, and consequently being capable of preventing respiratory diseases or inhibiting the progression of respiratory diseases into the severe stage.
4.WO/2023/003138POWDER, PILL, OR LIQUID FORM HERBAL MEDICINE COMPOSITION FOR FRACTURE RESTORATION AND BONE REGENERATION SPEED IMPROVEMENT, AND POWDER, PILL, OR LIQUID FORM HERBAL MEDICINE PREPARATION USING SAME
WO 26.01.2023
Int.Class A61K 36/232
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
232Angelica
Appl.No PCT/KR2022/006073 Applicant CHOI, Young Jin Inventor CHOI, Young Jin
The present invention relates to a powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement, and a powder, pill, or liquid form herbal medicine preparation using same and, more specifically, to a powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement and a powder, pill, or liquid form herbal medicine preparation using the same, the composition having medicinal materials capable of promoting fracture restoration and bone regeneration and medicinal materials capable of increasing digestion and absorption that are mixed to enable the promotion of fracture restoration and bone regeneration effects. A powder, pill, or liquid form herbal medicine composition for fracture restoration and bone regeneration speed improvement, of the present invention, comprises 20 parts by weight of Angelica gigas, 16 parts by weight of Dendrobium moniliforme, 12 parts by weight of Phlomis umbrosa, 10 parts by weight of Cervi cornu, 8 parts by weight of Cnidium officinale, 8 parts by weight of Astragalus membranaceus, 4 parts by weight of Achyranthes japonica, and 4 parts by weight of Massa Medicata Fermentata.
5.WO/2023/001842COMBINATION FOR USE FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA, HYPERLIPIDEMIA, CARDIOVASCULAR DISEASE AND METABOLIC SYNDROME
WO 26.01.2023
Int.Class A61K 9/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
Appl.No PCT/EP2022/070248 Applicant MEDA PHARMA S.P.A. Inventor ZANARDI, Andrea
The invention relates to a combination of: - naringin and - stanols for use in the treatment or prevention of hypercholesterolemia. The invention also relates to compositions comprising the combination.
6.WO/2023/003193COMPOSITION INCLUDING PAEONIFLORIN FOR PREVENTION OR TREATMENT OF CACHEXIA AND MUSCLE LOSS
WO 26.01.2023
Int.Class A61K 31/7048
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
70Carbohydrates; Sugars; Derivatives thereof
7042Compounds having saccharide radicals and heterocyclic rings
7048having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin
Appl.No PCT/KR2022/009127 Applicant CHUNG ANG UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATION Inventor YOON, Yoo Sik
The present invention relates to a pharmaceutical composition including paeoniflorin for prevention or treatment of cachexia and muscle loss. The pharmaceutical composition including paeoniflorin can be used for effectively preventing or treating cachexia and muscle loss.
7.WO/2023/001919USE OF BOSWELLIA FOR TREATING SARS-COV-2 INFECTION
WO 26.01.2023
Int.Class A61K 36/324
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18Magnoliophyta (angiosperms)
185Magnoliopsida (dicotyledons)
32Burseraceae (Frankincense family)
324Boswellia, e.g. frankincense
Appl.No PCT/EP2022/070413 Applicant VON KEUDELL, Christoph Inventor VON KEUDELL, Christoph
The present invention relates to the use of extracts from Boswellia species and pharmaceutical compositions comprising Boswellia extracts in the treatment of SARS-CoV-2 infection and related medical conditions.
8.WO/2023/003121COMPOSITION FOR INHIBITING CORONAVIRUS PROLIFERATION
WO 26.01.2023
Int.Class A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
Appl.No PCT/KR2022/003818 Applicant BEN'S LAB CO., LTD. Inventor JEONG, Jong Moon
The present invention relates to a composition for inhibiting coronavirus proliferation. The composition comprises epigallocatechin gallate (EGCG) as an active ingredient and thus is locally applicable in the mouth, nose or the like, thereby inhibiting a coronavirus, which induces respiratory diseases, from proliferating in oral or nasal epithelial cells and, as a result, preventing respiratory diseases or inhibiting development into serious respiratory diseases.
9.WO/2023/002049USE OF SILICONE-COATED GLASS CONTAINERS FOR LIQUID PLANT EXTRACTS
WO 26.01.2023
Int.Class A61J 1/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
1Containers specially adapted for medical or pharmaceutical purposes
Appl.No PCT/EP2022/070701 Applicant BIONORICA SE Inventor HABLON, Ilona
The present invention relates to the use of a closable glass container for storage of liquid plant extracts, the inner glass wall being coated with silicone.
10.WO/2023/001894EXTRACELLULAR VESICLES FROM MICROALGAE, THEIR PREPARATION, AND USES
WO 26.01.2023
Int.Class A61K 36/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
02Algae
05Chlorophycota or chlorophyta (green algae), e.g. Chlorella
Appl.No PCT/EP2022/070371 Applicant AGS THERAPEUTICS SAS Inventor DRITTANTI, Lila
Provided are compositions containing extracellular vesicles from microalgae (MEVs) that are exogenously loaded with bioactive cargo or other cargo of interest, such as for therapeutic, industrial, diagnostic, and cosmetic uses. The MEVs have a variety of applications as therapeutics, including as vaccines, as anti-cancer therapeutics, as diagnostics, and other such uses.